Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

2.75
+0.07002.61%
Post-market: 2.790.0400+1.45%19:40 EDT
Volume:177.71K
Turnover:484.56K
Market Cap:79.71M
PE:-1.13
High:2.79
Open:2.68
Low:2.63
Close:2.68
Loading ...
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Oct 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 01, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities